PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
Nature Medicine2014Vol. 20(7), pp. 741–747
Citations Over TimeTop 10% of 2014 papers
Khalid Bajou, Stéphanie Herkenne, Victor L. Thijssen, Salvino D’Amico, Ngoc-Quynh-Nhu Nguyen, Ann Bouché, Sébastien P. Tabruyn, Mohammed Srahna, Jean-Yves Carabin, Olivier Nivelles, Cécile Paques, Ivo Cornelissen, Michelle Lion, Agnès Noël, Ann Gils, Stefan Vinckier, Paul Declerck, Arjan W. Griffioen, Mieke Dewerchin, Joseph Martial, Peter Carmeliet, Ingrid Struman
Related Papers
- → Intermolecular Contact Regions in Urokinase Plasminogen Activator Receptor(2003)5 cited
- → Urokinase plasminogen activator receptor (uPAR) as a novel biomarker in prostate cancer.(2015)
- [The analysis of plasma Urokinase-type plasminogen activator and Urokinase-type plasminogen activator receptor which unknown factor nosebleed patients].(2007)
- Expressions and Significances of Urokinase-type Plasminogen Activator and its Receptor in Human Gliomas(2005)
- Association of plasma level of urokinase-type plasminogen activator,urokinase-type plasminogen activator receptor (uPAR),and plasminogen activator inhibitors type 1 with ovarian cancer(2007)